Christopher Jewell

Insider Reports History

Entity
Individual
Location
C/O Cartesian Therapeutics, Inc., 704 Quince Orchard Rd, Gaithersburg, MD
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Christopher Jewell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Jewell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Chief Scientific Officer Common Stock 39.9K $129K $3.23 Nov 20, 2024 Direct
Cartesian Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 76.4K $60.4K $0.79 Nov 20, 2024 Direct

Insider Reports Filed by Christopher Jewell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNAC Cartesian Therapeutics, Inc. Nov 20, 2024 2 $45.2K 4 Nov 21, 2024 Chief Scientific Officer
RNAC Cartesian Therapeutics, Inc. Nov 14, 2024 7 -$707K 4 Nov 18, 2024 Chief Scientific Officer
RNAC Cartesian Therapeutics, Inc. Apr 8, 2024 2 $0 4 Apr 10, 2024 Chief Scientific Officer
RNAC Cartesian Therapeutics, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Scientific Officer
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 1 $0 4 Nov 15, 2023 Chief Scientific Officer
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 0 $0 3 Nov 15, 2023 Chief Scientific Officer